Notice ID: 3cd913cab48f44478fb4ad9627fd1dd5Combined Synopsis/SolicitationArchived
Combines Synopsis Solicitation- NULISAseq Inflamma
Archived on September 26, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 12:00 PM EDT
- Posted
- September 2, 2026
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Office
- NATIONAL INSTITUTES OF HEALTH OLAO
- PSC
- Q301: REFERENCE LABORATORY TESTING
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75N98026Q01133
- Notice ID
- 3cd913cab48f44478fb4ad9627fd1dd5
Description
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q01133 and the solicitation is issued as a Notice of Intent (NOI) of a non-competitive (notice of intent) combined synopsis solicitation to award a contract or purchase order without providing for full or open competition (including brand-name).
This acquisition is conducted under the authority of the FAR Part 12.603¿ Streamlined solicitation for commercial products or commercial services, and is not expected to exceed the simplified acquisition threshold, and the authority of 41 U.S.C. 1901 and the statutory authority of FAR 6.302-3(a)(2)(ii).
(ii) The solicitation number is 75N98026Q01133 and the solicitation is issued as a Notice of Intent (NOI) of a non-competitive (notice of intent) combined synopsis solicitation to award a contract or purchase order without providing for full or open competition (including brand-name).
This acquisition is conducted under the authority of the FAR Part 12.603¿ Streamlined solicitation for commercial products or commercial services, and is not expected to exceed the simplified acquisition threshold, and the authority of 41 U.S.C. 1901 and the statutory authority of FAR 6.302-3(a)(2)(ii).
Award Overview
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
Sol_75N98026Q01133.pdf
280 KBAdded in Combined Synopsis/Solicitation version 3Posted
Lifecycle
- 3Version 3Combined Synopsis/SolicitationArchivedCurrent
Combines Synopsis Solicitation- NULISAseq Inflamma
Similar Opportunities
Additional Details
Solicitation Number
75N98026Q01133
Archive Date
Sep 26, 2026
Office Address
BETHESDA, MD, 20892